Sana Biotechnology, Inc. (SANA) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 9 Buy, 2 Hold.
The consensus price target is $9.00 (low: $7.00, high: $12.00), representing an upside of 158.6% from the current price $3.48.
Analysts estimate Earnings Per Share (EPS) of $-1.19 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.16 vs est $-1.19 (beat +2.2%). 2025: actual $-0.96 vs est $-0.86 (missed -11.2%). Analyst accuracy: 94%.
SANA Stock — 12-Month Price Forecast
$9.00
▲ +158.62% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for Sana Biotechnology, Inc., the average price target is $9.00, with a high forecast of $12.00, and a low forecast of $7.00.
The average price target represents a +158.62% change from the last price of $3.48.
Highest Price Target
$12.00
Average Price Target
$9.00
Lowest Price Target
$7.00
SANA Analyst Ratings
Buy
Based on 11 analysts giving stock ratings to Sana Biotechnology, Inc. in the past 3 months
EPS Estimates — SANA
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$1.16
vs Est –$1.19
▲ 2.2% off
2025
Actual –$0.96
vs Est –$0.86
▼ 10.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — SANA
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
